Why the study?
Does the '4-minus' haplotype of the NPR-A receptor gene affect NT-proBNP values in healthy individuals and patients with cardiovascular disorders?
Does the '4-minus' haplotype of the NPR-A receptor gene affect NT-proBNP values in healthy individuals and patients with cardiovascular disorders?
Genetic variation in the NPR-A gene contributes to baseline differences in NT-proBNP levels among healthy individuals, which may be important for interpreting this biomarker.
No takes yet. Share an insight, caveat, or question.
NT-proBNP interpretation may require genotype consideration in healthy individuals; leaves open impact in cardiovascular disorders.
Weber et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: